ASSERTIO THERAPEUTICS, INC. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2a292d05-e0bf-4851-b413-157e20e395cd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-194.4M | 2019-01-01 – 2019-12-31 | evidence 0001005201-20-000021 |
| FY 2018 | $43.7M | 2018-01-01 – 2018-12-31 | evidence 0001005201-19-000040 |
| FY 2017 | $-42.2M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001325 |
| FY 2016 | $24.5M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-000959 |
| FY 2015 | $-50.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010509 |
| FY 2014 | $236.8M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001308 |
| FY 2013 | $9.3M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-002523 |
| FY 2012 | $-30.4M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001503 |
| FY 2011 | $70.7M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-002308 |
| FY 2010 | $3.6M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-002308 |
| FY 2009 | $-22.1M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-002308 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ASSERTIO THERAPEUTICS, INC. — all facts · Revenue · Net Income